Media – Dr Raman Narang

Dr Raman Narang Media Coverage reflects his focus on scientific clarity, patient education, and responsible public health communication.

Dr Raman Narang is a Delhi-based Consultant Medical and Hemato-Oncologist frequently featured in leading Indian publications for his expertise in precision oncology, cancer genetics, immunotherapy, early detection, and evidence-based cancer care.

Featured In
Republic World • The Indian Express • Times of India • Hindustan Times • Business Standard • Financial Express • The Statesman • Dainik Jagran

For verified media collaborations or expert commentary requests:
contact@drramannarang.com


Media Coverage Dr Raman
Freedom of Press

Featured National Media Interviews & Expert Commentary

Republic World (January 2026)

Precision Oncology, Cancer Genetics, and Age-Specific Cancer Care
An in-depth expert feature on how genetic profiling and personalized treatment strategies are transforming cancer care delivery in India.

The Statesman (February 2026)

Improving Childhood Cancer Survival Rates in India
Discussion on structured treatment pathways, multidisciplinary care, and long-term survivorship planning in pediatric oncology.

Business Standard (January 2026)

Why Cervical Cancer Screening Should Be Every Woman’s 2026 Resolution
Expert commentary on HPV awareness, preventive oncology, and the importance of early screening strategies.

The Indian Express (December 2025)

Can Eggs with Antibiotic Traces Cause Cancer? Here’s the Evidence
Scientific clarification addressing common dietary cancer myths using evidence-based analysis.

Financial Express (September 2025)

How Blood Cancer Affects Children Differently Than Adults
Insights into biological differences between pediatric and adult hematological cancers and implications for treatment planning.

Times of India (August 2025)

World Lung Cancer Day: Awareness and Early Detection
Public health-focused discussion on smoking cessation, early diagnosis, and risk reduction strategies.

Hindustan Times (September 2024)

Immunotherapy: How It Differs from Chemotherapy and What Patients Should Know
Clear explanation of treatment mechanisms, patient selection, benefits, and side-effect considerations.

Dainik Jagran (English) (September 2025)

Night Symptom That May Indicate Blood Cancer
Awareness article highlighting early warning signs and the importance of timely medical evaluation.


Areas of Expertise Frequently Covered in Media

• Precision oncology and cancer genetics in India
• Immunotherapy versus chemotherapy
• Early detection and structured cancer screening
• Lung cancer and tobacco-related malignancies
• Cervical cancer prevention and HPV vaccination
• Childhood cancers and survivorship care
• Age-specific treatment personalization
• Evidence-based clarification of common cancer misconceptions


About Dr Raman Narang

Dr Raman Narang is a Consultant Medical and Hemato-Oncologist practicing in Delhi with a focused interest in precision oncology, cancer genetics, and structured second opinion consultations.

His clinical approach integrates molecular insights, international treatment guidelines, and patient-centered decision-making to optimize outcomes while preserving quality of life.

About | Second Opinion | Contact & Clinic Locations | Cancer Blog


Schedule a Consultation

If you are seeking:

• Personalized cancer treatment planning
• A structured second opinion
• Genetic-guided therapy consultation
• Expert review of diagnosis and treatment strategy

You may schedule a consultation below.

Frequently Asked Questions – Media Coverage

1. Why is media coverage important for a medical oncologist?

Media coverage reflects professional credibility and subject-matter expertise. When a medical oncologist is invited to provide expert commentary in national publications, it signals recognition by independent journalistic platforms.

Such features often involve evidence-based insights on cancer awareness, precision oncology, screening guidelines, and evolving treatment strategies. Media presence supports public education while reinforcing clinical authority.


2. What type of topics does Dr Raman Narang contribute to in the media?

Dr Raman Narang contributes expert commentary on topics including:

  • Precision oncology and molecular profiling
  • Cancer genetics and hereditary risk
  • Early cancer detection and screening awareness
  • Geriatric and young adult oncology
  • Evidence-based cancer treatment updates

These discussions are typically aligned with public health awareness, clinical research developments, and patient education initiatives.


3. Does media coverage reflect clinical expertise?

Media features are not advertisements. Reputed publications typically seek commentary from recognized specialists with domain expertise.

Being quoted or featured in established news platforms indicates that the oncologist is regarded as a credible source for accurate, research-backed medical insights. It reflects thought leadership rather than promotional positioning.


4. How does media visibility benefit patients?

Media engagement helps translate complex oncology concepts into accessible information for the public. Patients and caregivers often encounter cancer-related topics through news platforms before consulting specialists.

Expert commentary in media supports informed decision-making by clarifying misconceptions, highlighting screening importance, and explaining evolving treatment options such as targeted therapy or immunotherapy.


5. Are media articles a substitute for medical consultation?

No. Media interviews and expert features are educational in nature. They provide general insights on cancer prevention, diagnosis, and treatment trends but cannot replace individualized clinical evaluation.

Personalized treatment decisions require comprehensive medical assessment, pathology review, imaging interpretation, and structured oncology consultation.

Scroll to Top